TreeFrog Therapeutics Enters Into Pioneering Research Collaboration in Immuno-Oncology With the University of Pittsburgh Read more
European Commission Approves DARZALEX (daratumumab)-SC Quadruplet Regimen for Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma Read more
Lilly’s Kisunla Gains Marketing Authorization in Great Britain for Alzheimer’s Treatment in Select Adult Patients Read more
Alvotech and Teva Receive FDA Approval for Expanded SELARSDI (ustekinumab-aekn) Presentation, Aligning Indications with Stelara (ustekinumab) Read more
FDA Approves Pfizer’s RSV Vaccine ABRYSVO for Adults Aged 18 to 59 at Increased Risk for Disease Read more